Articles related to MEDICARE

Vertical consolidation in healthcare raises concerns about corporatization pitting profit maximization against physicians’ ethical obligations to prioritize patient interests.

Higher telehealth use correlates with increased healthcare utilization and costs, indicating that while telehealth improves access, it may also lead to higher rates of ambulatory care-sensitive hospitalizations.

Oncology practitioners have a new opportunity to ethically enhance their E/M billing through Medicare’s code G2211, which emphasizes the value of sustained care and complexity in patient management.

The Inflation Reduction Act’s out-of-pocket cap on Medicare Part D spending marks a pivotal shift in healthcare economics, potentially altering prescription drug cost dynamics for millions of enrollees. Physicians should be aware of these changes to better support and inform their patients navigating these new financial landscapes.

Stay abreast of the latest HCPCS updates crucial for oncology practice, including new codes for advanced cancer treatments and essential guidelines for principal illness navigation services, to ensure compliance and optimize reimbursement.

Discover how the Inflation Reduction Act influences pharmaceutical innovation and drug pricing. Learn why delaying drug launches might not be an optimal strategy.